Trial Profile
Index of osteoporotic risk associated with denosumab treatment in postmenopausal osteoporotic women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics
- 14 Dec 2015 New trial record